DE2521523A1 - Lactamverbindungen und konjugate - Google Patents

Lactamverbindungen und konjugate

Info

Publication number
DE2521523A1
DE2521523A1 DE19752521523 DE2521523A DE2521523A1 DE 2521523 A1 DE2521523 A1 DE 2521523A1 DE 19752521523 DE19752521523 DE 19752521523 DE 2521523 A DE2521523 A DE 2521523A DE 2521523 A1 DE2521523 A1 DE 2521523A1
Authority
DE
Germany
Prior art keywords
antigen
group
carbon atoms
oxygen
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19752521523
Other languages
German (de)
English (en)
Inventor
Gunner Van Bolz
Richard K Leute
Prithipal Dr Singh
Michael J Soffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syva Co
Original Assignee
Syva Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syva Co filed Critical Syva Co
Publication of DE2521523A1 publication Critical patent/DE2521523A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9446—Antibacterials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyrrole Compounds (AREA)
DE19752521523 1974-06-28 1975-05-14 Lactamverbindungen und konjugate Ceased DE2521523A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48402674A 1974-06-28 1974-06-28

Publications (1)

Publication Number Publication Date
DE2521523A1 true DE2521523A1 (de) 1976-01-15

Family

ID=23922433

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752521523 Ceased DE2521523A1 (de) 1974-06-28 1975-05-14 Lactamverbindungen und konjugate

Country Status (5)

Country Link
JP (1) JPS511632A (enExample)
CA (1) CA1037475A (enExample)
DE (1) DE2521523A1 (enExample)
FR (1) FR2276317A1 (enExample)
GB (1) GB1511571A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0410280A1 (de) * 1989-07-26 1991-01-30 Roche Diagnostics GmbH Heterobifunktionelle Verbindungen

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069105A (en) * 1977-03-03 1978-01-17 Syva Company Lidocaine antigens and antibodies
US4156081A (en) * 1977-04-15 1979-05-22 Syva Company Theophylline antigens and antibodies
IL68364A (en) * 1982-06-01 1986-07-31 Miles Lab Ethosuximide immunogens,antibodies prepared therefrom and the use of such antibodies in immunoassays
DE3682105D1 (de) * 1985-04-01 1991-11-28 Abbott Lab Probe, tracers, immunogene und antikoerper von ethosuximid.
CN101863834B (zh) * 2010-06-29 2012-10-10 渤海大学 S-羧甲基-5,5-二苯基-2-硫代海因的制备方法
KR102267919B1 (ko) 2018-06-28 2021-06-23 주식회사 고영테크놀러지 기판에 실장된 부품의 실장 불량 원인을 결정하는 전자 장치 및 방법
WO2020111756A1 (ko) 2018-11-27 2020-06-04 주식회사 고영테크놀러지 기판에 대한 검사 결과를 표시하는 전자 장치 및 방법
CN115372501B (zh) * 2022-07-27 2024-03-26 广州科曼生物科技有限公司 一种浙贝母或湖北贝母对照提取物及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RÖMPP: Chemie-Lexikon, Stichwort Hydantoiue, 7. Aufl., Frankh'sche Verlagshandlung, Stuttgart 1973 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0410280A1 (de) * 1989-07-26 1991-01-30 Roche Diagnostics GmbH Heterobifunktionelle Verbindungen

Also Published As

Publication number Publication date
JPS638427B2 (enExample) 1988-02-23
CA1037475A (en) 1978-08-29
GB1511571A (en) 1978-05-24
JPS511632A (en) 1976-01-08
FR2276317A1 (fr) 1976-01-23
FR2276317B1 (enExample) 1979-04-27

Similar Documents

Publication Publication Date Title
EP0133674B1 (de) Neue Nitroxylverbindungen, Verfahren zu deren Herstellung und diese enthaltende diagnostische Mittel
DE3877406T2 (de) Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung.
DE3856358T3 (de) Für Tests verwendbare chemilumineszierende Ester, Thioester und Amide
DE4310142A1 (de) Immunologisch aktive Konjugate und ein Verfahren zu ihrer Herstellung
DE19630102A1 (de) Neue aktivierte Amphetamine
CH621800A5 (enExample)
DE2065635B2 (de) 10-Dioxo-11 -methyldibenzothiazepinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE2649903A1 (de) Dibenz eckige klammer auf b,f eckige klammer zu azepin-verbindungen und damit erzeugte antikoerper
DE2521523A1 (de) Lactamverbindungen und konjugate
DE2923368A1 (de) Neue 5-fluor-( beta -uridin oder 2'-desoxy- beta -uridin)-derivate, verfahren zur herstellung derselben und carcinostatische mittel mit einem gehalt derselben
EP0276803A1 (de) 1-(4-Hydroxy-3,5-di-tert.-butyl-benzoyl)-homopiperazin, verschiedene von dessen Derivaten, Verfahren zur Herstellung dieser Verbindungen, die sie enthaltenden Arzneimittel und ihre Verwendung
DE3209276A1 (de) Arzneimittel mit antihypoxischer und ischaemie-protektiver wirkung
DE3044740A1 (de) Nucleosidderivate, ihre herstellung und pharmazeutische mittel
DE2263100C2 (de) 5,5-Dimethyl-8-(3-methyl-2-octyl)-10-[4-(piperidino)-butyryloxy]-2-(2-propinyl)-1,2,3,4-tetrahydro-5H-[1]-benzopyrano[3,4-d]pyridin, Verfahren zu dessen Herstellung und die Verbindung enthaltende Arzneimittel
DE2602643A1 (de) 1,2-benzisothiazolinone-3, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2716536A1 (de) Bestimmung von methadon
DE69731649T2 (de) Konjugate und spezifische immuntests des methadonmetaboliten 2-ethylidin-1,5-dimethyl-3,3-diphenyl-3,3-diphenylpyrrolidin
DE2205745A1 (de) Neue durch den n-cyaniminorest substituierten heterocyclen und verfahren zu ihrer herstellung
AT371460B (de) Verfahren zur herstellung neuer benzopyranderivate und ihrer salze
DE2720545A1 (de) Neue chinazolinderivate, ihre herstellung und pharmazeutische mittel
DE2914842A1 (de) Reagenzien zur verwendung bei bindungsproben beim nachweis von diphenylhydantoin
DE1239692B (de) Verfahren zur Herstellung von 3-(alpha-Arylalkyl)-sydnoniminen, ihren Salzen und N-Acylderivaten
EP0049860A1 (de) Verfahren zur Herstellung von reaktiven, kupplungsfähigen Derivaten der Schilddrüsenhormone T3 und T4 und deren Verwendung
CH642668A5 (de) 2,6-diaminonebularine, verfahren zu deren herstellung und sie enthaltende pharmazeutische praeparate.
DE2535147A1 (de) 2-thiol-4,5-diphenyloxazol-s-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8131 Rejection